Australian Pharmaceutical Industries Ltd
ASX:API
Australian Pharmaceutical Industries Ltd
Cash from Operating Activities
Australian Pharmaceutical Industries Ltd
Cash from Operating Activities Peer Comparison
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Australian Pharmaceutical Industries Ltd
ASX:API
|
Cash from Operating Activities
AU$71.8m
|
CAGR 3-Years
10%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
N/A
|
|
Paragon Care Ltd
ASX:PGC
|
Cash from Operating Activities
AU$27.4m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
21%
|
CAGR 10-Years
N/A
|
|
Sigma Healthcare Ltd
ASX:SIG
|
Cash from Operating Activities
AU$42m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
38%
|
CAGR 10-Years
-6%
|
|
Cronos Australia Ltd
ASX:CAU
|
Cash from Operating Activities
AU$9.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Australian Pharmaceutical Industries Ltd's Cash from Operating Activities?
Cash from Operating Activities
71.8m
AUD
Based on the financial report for Aug 31, 2021, Australian Pharmaceutical Industries Ltd's Cash from Operating Activities amounts to 71.8m AUD.
What is Australian Pharmaceutical Industries Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
-3%
Over the last year, the Cash from Operating Activities growth was -67%. The average annual Cash from Operating Activities growth rates for Australian Pharmaceutical Industries Ltd have been 10% over the past three years , -3% over the past five years .